Asthma — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — GINA Step 3: low-dose ICS-LABA maintenance
This patient has partly controlled asthma with symptoms >2 days/week and nocturnal symptoms. This corresponds to GINA Step 3. The preferred controller is low-dose ICS-LABA (e.g. budesonide-formoterol) as maintenance therapy with as-needed low-dose ICS-formoterol as reliever. GINA 2024 recommends ICS-formoterol as the preferred reliever at all steps.
Reference: GINA – 2024 – Global Strategy for Asthma Management and Prevention